KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $66,902,906 | -10.0% | 7,335,845 | +4.4% | 3.62% | -9.1% |
Q2 2023 | $74,360,916 | -7.5% | 7,028,442 | +6.9% | 3.98% | +17.1% |
Q1 2023 | $80,391,887 | +1.6% | 6,573,335 | +3.1% | 3.40% | +2.2% |
Q4 2022 | $79,136,274 | +42.6% | 6,376,815 | +56.9% | 3.32% | +44.2% |
Q3 2022 | $55,502,000 | -24.6% | 4,063,128 | +1.1% | 2.30% | -17.7% |
Q2 2022 | $73,632,000 | +17.6% | 4,017,000 | +3.2% | 2.80% | +46.4% |
Q1 2022 | $62,600,000 | +25.2% | 3,893,019 | +9.0% | 1.91% | +97.5% |
Q4 2021 | $50,014,000 | +8.5% | 3,572,419 | +45.2% | 0.97% | +24.7% |
Q3 2021 | $46,080,000 | +33.2% | 2,460,202 | +48.3% | 0.78% | +50.1% |
Q2 2021 | $34,584,000 | +67.0% | 1,658,706 | +126.5% | 0.52% | +69.0% |
Q1 2021 | $20,705,000 | +133.5% | 732,415 | +169.8% | 0.31% | +140.9% |
Q4 2020 | $8,867,000 | +143.2% | 271,500 | +128.2% | 0.13% | +92.4% |
Q3 2020 | $3,646,000 | – | 119,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |